Satavaptan

Satavaptan is a vasopressin receptor antagonist used in the treatment of hyponatremia (low blood sodium levels) associated with cirrhosis, and heart failure. It was developed by Sanofi-Aventis.

Etymology[edit | edit source]

The term "Satavaptan" is derived from the Sanskrit word "Sata", meaning "hundred", and "vaptan", which is a derivative of the term "vasopressin antagonist". This name signifies the drug's ability to antagonize the effects of vasopressin, a hormone that regulates the body's water balance, on a hundred different levels.

Mechanism of Action[edit | edit source]

Satavaptan works by blocking the action of vasopressin, a hormone that regulates the body's water balance. This results in an increase in urine production, which helps to raise blood sodium levels.

Clinical Use[edit | edit source]

Satavaptan is used in the treatment of hyponatremia associated with conditions such as cirrhosis and heart failure. It is administered orally and is available in tablet form.

Side Effects[edit | edit source]

Common side effects of Satavaptan include dry mouth, thirst, and increased urination. In some cases, it may also cause low blood pressure (hypotension), dizziness, and kidney problems.

Related Terms[edit | edit source]

See Also[edit | edit source]

Satavaptan Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.